Delivery Order SPE2DB20D7059-SPE2DB25FQBN8
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg Ondansetron orally disintegrating tablets in 30-count packages, with a ceiling value of $10,433.62 and a period of performance through June 4, 2024. The contract is a firm-fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages, with a total ceiling value of $8,607.73 and a completion date of November 14, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has a firm fixed price of $1,539.86 and a completion date of February 20, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract, valued at $2,801.40, is a firm fixed-price Delivery Order with a performance period through August 15, 2024. It is not set-aside for any socioeconomic program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of Ondansetron Orally Disintegrating Tablets, 4mg, 30-count, with a ceiling value of $10,406.84 and a performance period ending on July 9, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in quantities of 30 per package. The award has a ceiling value of $20,590.05 and runs from March 2025 to March 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in...
- This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets, with a ceiling value of $14,549.08 and a completion date of May 17, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has a ceiling value of $7,762.34 and a period of performance through August 19, 2024. It is a firm-fixed price contract and does not utilize a set-aside designation. As a supplier to numerous federal agencies, AmerisourceBergen leverages its...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4 milligram Ondansetron orally disintegrating tablets in 30-count packages. The $2,715.52 firm-fixed-price contract has an ultimate completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,481,629 units of the 8 mg Ondansetron orally disintegrating tablet in 30-count packages. The firm-fixed-price contract, valued at $3,182.49, has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQBN8Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in quantities of 30 tablets per package. The contract has a firm fixed price of $4,947.60 and a completion date of March 13, 2025. This appears to be an open competition contract, as no set-aside designation is mentioned. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 3/12/25 |